An ancient founder mutation in PROKR2 impairs human reproduction

Human Molecular Genetics

Volumn 21, Issue 19, 2012, Pages 4314-4324

  Avbelj stefanija, Magdalena ^a,d   Jeanpierre, Marc ^e   Sykiotis, Gerasimos P ^f   Young, Jacques ^g   Quinton, Richard ^h,i   Abreu, Ana Paula ^j   Plummer, Lacey ^a   Au, Margaret G ^a   Balasubramanian, Ravikumar ^a   Dwyer, Andrew A ^k   Florez, Jose C ^b,l,m   Cheetham, Timothy ^h,i   Pearce, Simon H ^h   Purushothaman, Radhika ⁿ   Schinzel, Albert ^o   Pugeat, Michel ^p   Jacobson dickman, Elka E ⁿ   Ten, Svetlana ⁿ   Latronico, Ana Claudia ^j   Gusella, James F ^c,l,m   Dode, Catherine ^e   Crowley, William F ^m   Pitteloud, Nelly ^k   more..

^a Harvard Reproductive Endocrine Sciences Center   (United States)

^b Center for Human Genetic Research   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^e INSTITUT COCHIN   (France)

^f UNIVERSITY OF PATRAS   (Greece)

^g UNIVERSITÉ PARIS SACLAY   (France)

^h NEWCASTLE UNIVERSITY   (United Kingdom)

ⁱ NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^j UNIVERSITY OF SÃO PAULO   (Brazil)

^k LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^l BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^m HARVARD MEDICAL SCHOOL   (United States)

ⁿ SUNY DOWNSTATE MEDICAL CENTER   (United States)

^o UNIVERSITY OF ZURICH   (Switzerland)

^p UNIVERSITÉ LYON 1   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; GONADOTROPIN; PROKINETICIN RECEPTOR 2; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETICS; HAPLOTYPE; HETEROZYGOTE; HORMONE DEFICIENCY; HUMAN; INHERITANCE; MALE; PRIORITY JOURNAL; REPRODUCTION;

CONTINENTAL POPULATION GROUPS; EVOLUTION, MOLECULAR; FEMALE; FOUNDER EFFECT; GONADOTROPIN-RELEASING HORMONE; HAPLOTYPES; HUMANS; MALE; MUTATION, MISSENSE; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; REPRODUCTION;

EID: 84866428240     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds264     Document Type: Article

References (62)

1. Knobil, E. (1980) The neuroendocrine control of the menstrual cycle. Recent Prog. Horm. Res., 36, 53-88.
2. Crowley, W.F. Jr, Filicori, M., Spratt, D.I. and Santoro, N.F. (1985) The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog. Horm. Res., 41, 473-531.
3. Sykiotis, G.P., Pitteloud, N., Seminara, S.B., Kaiser, U.B. and Crowley, W.F. Jr. (2010) Deciphering genetic disease in the genomic era: the model of GnRH deficiency. Sci. Transl. Med., 2, 32rv2.
4. Seminara, S.B., Hayes, F.J. and Crowley, W.F. Jr. (1998) Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocr. Rev., 19, 521-539.
5. Martin, C., Balasubramanian, R., Dwyer, A.A., Au, M.G., Sidis, Y., Kaiser, U.B., Seminara, S.B., Pitteloud, N., Zhou, Q.Y. and Crowley, W.F. Jr. (2011) The role of the prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations. Endocr. Rev., 32, 225-246.
6. Cheng, M.Y., Bullock, C.M., Li, C., Lee, A.G., Bermak, J.C., Belluzzi, J., Weaver, D.R., Leslie, F.M. and Zhou, Q.Y. (2002) Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature, 417, 405-410.
7. Cheng, M.Y., Leslie, F.M. and Zhou, Q.Y. (2006) Expression of prokineticins and their receptors in the adult mouse brain. J. Comp. Neurol., 498, 796-809.
8. Ng, K.L., Li, J.D., Cheng, M.Y., Leslie, F.M., Lee, A.G. and Zhou, Q.Y. (2005) Dependence of olfactory bulb neurogenesis on prokineticin 2 signaling. Science, 308, 1923-1927.
9. Pitteloud, N., Zhang, C., Pignatelli, D., Li, J.D., Raivio, T., Cole, L.W., Plummer, L., Jacobson-Dickman, E.E., Mellon, P.L., Zhou, Q.Y. et al. (2007) Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc. Natl Acad. Sci. USA, 104, 17447-17452.
10. Matsumoto, S., Yamazaki, C., Masumoto, K.H., Nagano, M., Naito, M., Soga, T., Hiyama, H., Matsumoto, M., Takasaki, J., Kamohara, M. et al. (2006) Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. Proc. Natl Acad. Sci. USA, 103, 4140-4145.
11. Dode, C., Teixeira, L., Levilliers, J., Fouveaut, C., Bouchard, P., Kottler, M.L., Lespinasse, J., Lienhardt-Roussie, A., Mathieu, M., Moerman, A. et al. (2006) Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet., 2, e175.
12. Cole, L.W., Sidis, Y., Zhang, C., Quinton, R., Plummer, L., Pignatelli, D., Hughes, V.A., Dwyer, A.A., Raivio, T., Hayes, F.J. et al. (2008) Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum. J. Clin. Endocrinol. Metab., 93, 3551-3559.
13. Abreu, A.P., Trarbach, E.B., de Castro, M., Frade Costa, E.M., Versiani, B., Matias Baptista, M.T., Garmes, H.M., Mendonca, B.B. and Latronico, A.C. (2008) Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome. J. Clin. Endocrinol. Metab., 93, 4113-4118.
14. Sinisi, A.A., Asci, R., Bellastella, G., Maione, L., Esposito, D., Elefante, A., De Bellis, A., Bellastella, A. and Iolascon, A. (2008) Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report. Hum. Reprod., 23, 2380-2384.
15. Canto, P., Munguia, P., Soderlund, D., Castro, J.J. and Mendez, J.P. (2009) Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1. J. Androl., 30, 41-45.
16. Sarfati, J., Guiochon-Mantel, A., Rondard, P., Arnulf, I., Garcia-Pinero, A., Wolczynski, S., Brailly-Tabard, S., Bidet, M., Arroyo, R., Mathieu, M. et al. (2010) A comparative phenotypic study of Kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes. J. Clin. Endocrinol. Metab., 95, 659- 669.
17. Sykiotis, G.P., Plummer, L., Hughes, V.A., Au, M., Durrani, S., Nayak-Young, S., Dwyer, A.A., Quinton, R., Hall, J.E., Gusella, J.F. et al. (2010) Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc. Natl Acad. Sci. USA, 107, 15140-15144.
18. de Roux, N., Young, J., Misrahi, M., Genet, R., Chanson, P., Schaison, G. and Milgrom, E. (1997) A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N. Engl. J. Med., 337, 1597-1602.
19. Layman, L.C., Cohen, D.P., Jin, M., Xie, J., Li, Z., Reindollar, R.H., Bolbolan, S., Bick, D.P., Sherins, R.R., Duck, L.W. et al. (1998) Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat. Genet., 18, 14-15.
20. Costa, E.M., Bedecarrats, G.Y., Mendonca, B.B., Arnhold, I.J., Kaiser, U.B. and Latronico, A.C. (2001) Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction. J. Clin. Endocrinol. Metab., 86, 2680-2686.
21. Bhagavath, B., Ozata, M., Ozdemir, I.C., Bolu, E., Bick, D.P., Sherins, R.J. and Layman, L.C. (2005) The prevalence of gonadotropin-releasing hormone receptor mutations in a large cohort of patients with hypogonadotropic hypogonadism. Fertil. Steril., 84, 951-957.
22. Cerrato, F., Shagoury, J., Kralickova, M., Dwyer, A., Falardeau, J., Ozata, M., Van Vliet, G., Bouloux, P., Hall, J.E., Hayes, F.J. et al. (2006) Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadism. Eur. J. Endocrinol., 155 (Suppl. 1), S3-S10.
23. Kim, H.G., Pedersen-White, J., Bhagavath, B. and Layman, L.C. (2010) Genotype and phenotype of patients with gonadotropin-releasing hormone receptor mutations. Front. Horm. Res., 39, 94-110.
24. Topaloglu, A.K., Reimann, F., Guclu, M., Yalin, A.S., Kotan, L.D., Porter, K.M., Serin, A., Mungan, N.O., Cook, J.R., Ozbek, M.N. et al. (2009) TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat. Genet., 41, 354-358.
25. Young, J., Bouligand, J., Francou, B., Raffin-Sanson, M.L., Gaillez, S., Jeanpierre, M., Grynberg, M., Kamenicky, P., Chanson, P., Brailly-Tabard, S. et al. (2010) TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans. J. Clin. Endocrinol. Metab., 95, 2287-2295.
26. Gianetti, E., Tusset, C., Noel, S.D., Au, M.G., Dwyer, A.A., Hughes, V.A., Abreu, A.P., Carroll, J., Trarbach, E., Silveira, L.F. et al. (2010) TAC3/TACR3 Mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. J. Clin. Endocrinol. Metab., 95, 2857-2867.
27. Caronia, L., Martin, C., Sykiotis, G., Welt, C., Quinton, R., Avbelj, M., Plummer, L., Thambundit, A., Nayak-Young, S., Hughes, V. et al. (2011) A genetic basis for functional hypothalamic amenorrhea. N. Engl. J. Med., 364, 215-225.
28. Monnier, C., Dode, C., Fabre, L., Teixeira, L., Labesse, G., Pin, J.P., Hardelin, J.P. and Rondard, P. (2009) PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity. Hum. Mol. Genet., 18, 75-81.
29. Barrett, J.C., Fry, B., Maller, J. and Daly, M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
30. Hanein, S., Perrault, I., Gerber, S., Delphin, N., Benezra, D., Shalev, S., Carmi, R., Feingold, J., Dufier, J.L., Munnich, A. et al. (2008) Population history and infrequent mutations: how old is a rare mutation? GUCY2D as a worked example. Eur. J. Hum. Genet., 16, 115-123.
31. Vagenakis, G.A., Sgourou, A., Papachatzopoulou, A., Kourounis, G., Papavassiliou, A.G. and Georgopoulos, N.A. (2005) The gonadotropin-releasing hormone (GnRH)-1 gene, the GnRH receptor gene, and their promoters in patients with idiopathic hypogonadotropic hypogonadism with or without resistance to GnRH action. Fertil. Steril., 84, 1762-1765.
32. Topaloglu, A.K., Lu, Z.L., Farooqi, I.S., Mungan, N.O., Yuksel, B., O'Rahilly, S. and Millar, R.P. (2006) Molecular genetic analysis of normosmic hypogonadotropic hypogonadism in a Turkish population: identification and detailed functional characterization of a novel mutation in the gonadotropin-releasing hormone receptor gene. Neuroendocrinology, 84, 301-308.
33. Pitteloud, N., Quinton, R., Pearce, S., Raivio, T., Acierno, J., Dwyer, A., Plummer, L., Hughes, V., Seminara, S., Cheng, Y.Z. et al. (2007) Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J. Clin. Invest., 117, 457-463.
34. Shaw, N.D., Seminara, S.B., Welt, C.K., Au, M.G., Plummer, L., Hughes, V.A., Dwyer, A.A., Martin, K.A., Quinton, R., Mericq, V. et al. (2011) Expanding the phenotype and genotype of female GnRH deficiency. J. Clin. Endocrinol. Metab., 96, E566-E576.
35. Nachtigall, L.B., Boepple, P.A., Pralong, F.P. and Crowley, W.F. Jr. (1997) Adult-onset idiopathic hypogonadotropic hypogonadism-a treatable form of male infertility. N. Engl. J. Med., 336, 410-415.
36. Schinzel, A., Lorda-Sanchez, I., Binkert, F., Carter, N.P., Bebb, C.E., Ferguson-Smith, M.A., Eiholzer, U., Zachmann, M. and Robinson, W.P. (1995) Kallmann syndrome in a boy with a t(1;10) translocation detected by reverse chromosome painting. J. Med. Genet., 32, 957-961.
37. Crow, J.F. and Kimura, M. (1979) Efficiency of truncation selection. Proc. Natl Acad. Sci. USA, 76, 396-399.
38. Bouligand, J., Ghervan, C., Tello, J.A., Brailly-Tabard, S., Salenave, S., Chanson, P., Lombes, M., Millar, R.P., Guiochon-Mantel, A. and Young, J. (2009) Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation. N. Engl. J. Med., 360, 2742-2748.
39. Casals, T., Vazquez, C., Lazaro, C., Girbau, E., Gimenez, F.J. and Estivill, X. (1992) Cystic fibrosis in the Basque country: high frequency of mutation delta F508 in patients of Basque origin. Am. J. Hum. Genet., 50, 404-410.
40. Pier, G.B., Grout, M., Zaidi, T., Meluleni, G., Mueschenborn, S.S., Banting, G., Ratcliff, R., Evans, M.J. and Colledge, W.H. (1998) Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature, 393, 79-82.
41. Hogenauer, C., Santa Ana, C.A., Porter, J.L., Millard, M., Gelfand, A., Rosenblatt, R.L., Prestidge, C.B. and Fordtran, J.S. (2000) Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion. Am. J. Hum. Genet., 67, 1422-1427.
42. Zschocke, J. (2003) Phenylketonuria mutations in Europe. Hum. Mutat., 21, 345-356.
43. Gardiner, J.V., Bataveljic, A., Patel, N.A., Bewick, G.A., Roy, D., Campbell, D., Greenwood, H.C., Murphy, K.G., Hameed, S., Jethwa, P.H. et al. (2009) Prokineticin 2 is a hypothalamic neuropeptide which potently inhibits food intake. Diabetes, 59, 397-406.
44. Jethwa, P.H., I'Anson, H., Warner, A., Prosser, H.M., Hastings, M.H., Maywood, E.S. and Ebling, F.J. (2008) Loss of prokineticin receptor 2 signaling predisposes mice to torpor. Am. J. Physiol. Regul. Integr. Comp. Physiol., 294, R1968-R1979.
45. Chan, Y.M., de Guillebon, A., Lang-Muritano, M., Plummer, L., Cerrato, F., Tsiaras, S., Gaspert, A., Lavoie, H.B., Wu, C.H., Crowley, W.F. Jr et al. (2009) GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. Proc. Natl Acad. Sci. USA, 106, 11703-11708.
46. Claustres, M., Guittard, C., Bozon, D., Chevalier, F., Verlingue, C., Ferec, C., Girodon, E., Cazeneuve, C., Bienvenu, T., Lalau, G. et al. (2000) Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France. Hum. Mutat., 16, 143-156.
47. Pitteloud, N., Hayes, F.J., Boepple, P.A., DeCruz, S., Seminara, S.B., MacLaughlin, D.T. and Crowley, W.F. Jr (2002) The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab., 87, 152-160.
48. Doty, R.L., Applebaum, S., Zusho, H. and Settle, R.G. (1985) Sex differences in odor identification ability: a cross-cultural analysis. Neuropsychologia, 23, 667-672.
49. Hardelin, J.P., Levilliers, J., Blanchard, S., Carel, J.C., Leutenegger, M., Pinard-Bertelletto, J.P., Bouloux, P. and Petit, C. (1993) Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndrome. Hum. Mol. Genet., 2, 373-377.
50. Dode, C., Levilliers, J., Dupont, J.M., De Paepe, A., Le Du, N., Soussi-Yanicostas, N., Coimbra, R.S., Delmaghani, S., Compain-Nouaille, S., Baverel, F. et al. (2003) Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat. Genet., 33, 463-465.
51. Falardeau, J., Chung, W.C., Beenken, A., Raivio, T., Plummer, L., Sidis, Y., Jacobson-Dickman, E.E., Eliseenkova, A.V., Ma, J., Dwyer, A. et al. (2008) Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J. Clin. Invest., 118, 2822-2831.
52. De Roux, N., Genin, E., Carel, J.C., Matsuda, F., Chaussain, J.L. and Milgrom, E. (2003) Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc. Natl Acad. Sci. USA, 100, 10972-10976.
53. Den Dunnen, J.T. and Antonarakis, S.E. (2001) Nomenclature for the description of human sequence variations. Hum. Genet., 109, 121-124.
54. De Bakker, P.I., Yelensky, R., Pe'er, I., Gabriel, S.B., Daly, M.J. and Altshuler, D. (2005) Efficiency and power in genetic association studies. Nat. Genet., 37, 1217-1223.
55. Gabriel, S., Ziaugra, L. and Tabbaa, D. (2009) SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr. Protoc. Hum. Genet., 60, 2.12.1-2.12.16.
56. Storm, N., Darnhofer-Patel, B., Van Den Boom, D. and Rodi, C.P. (2003) MALDI-TOF mass spectrometry-based SNP genotyping. Methods Mol. Biol., 212, 241-262.
57. McPeek, M.S. and Strahs, A. (1999) Assessment of linkage disequilibrium by the decay of haplotype sharing, with application to fine-scale genetic mapping. Am. J. Hum. Genet., 65, 858-875.
58. Tremblay, M. and Vezina, H. (2000) New estimates of intergenerational time intervals for the calculation of age and origins of mutations. Am. J. Hum. Genet., 66, 651-658.
59. Shojaei, F., Wu, X., Zhong, C., Yu, L., Liang, X.H., Yao, J., Blanchard, D., Bais, C., Peale, F.V., Van Bruggen, N. et al. (2007) Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature, 450, 825-831.
60. Shojaei, F., Singh, M., Thompson, J.D. and Ferrara, N. (2008) Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. Proc. Natl Acad. Sci. USA, 105, 2640-2645.
61. Monnier, J. and Samson, M. (2008) Cytokine properties of prokineticins. FEBS J., 275, 4014-4021.
62. Li, J.D., Hu, W.P. and Zhou, Q.Y. (2009) Disruption of the circadian output molecule prokineticin 2 results in anxiolytic and antidepressant-like effects in mice. Neuropsychopharmacology, 34, 367-373.